FGF19, FGF21 and an FGFR1/β-Klotho-activating Antibody Act on the Nervous System to Regulate Body Weight and Glycemia

Despite their different physiologic functions as hormonal regulators of fed and fasted metabolism, pharmacologic administration of FGF19 and FGF21 similarly cause increases in energy expenditure, weight loss and enhanced insulin sensitivity in obese animals. Here, in genetic loss-of-function studies...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cell Metab
Asıl Yazarlar: Lan, Tian, Morgan, Donald A., Rahmouni, Kamal, Sonoda, Junichiro, Fu, Xiaorong, Burgess, Shawn C., Holland, William L., Kliewer, Steven A., Mangelsdorf, David J.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2017
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5679468/
https://ncbi.nlm.nih.gov/pubmed/28988823
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cmet.2017.09.005
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller